Back to search

Article

CALM1 promotes progression and dampens chemosensitivity to EGFR inhibitor in esophageal squamous cell carcinoma

2021-01-14

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Calmodulin1 (CALM1) has been identified as one of the overexpression genes in a variety of cancers and EGFR inhibitor have been widely used in clinical treatment but it is unknown whether CALM1 and epidermal growth factor receptor (EGFR) have a synergistic effect in esophageal squamous cell carcinoma (ESCC). The aim of the present study was to explore the synerg...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
36245398-132b-564c-b8d2-c01a9028fe55
DOI
10.21203/rs.3.rs-65402/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CALM1 promotes progression and dampens chemosensitivity to EGFR inhibitor in esophageal squamous cell carcinomaDOI 10.21203/rs.3.rs-65402/v2
Select a neighboring publication to make it the new centre.